Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Dongxin Pharmaceutical Technology is a prominent Chinese pharmaceutical enterprise specializing in the research, development, and production of external preparations and chemical drugs. Headquartered in Wuhan's East Lake High-tech Development Zone, the company is a key member of the Dongxin Pharmaceutical Group. Its core business revolves around dermatological, gynecological, and pediatric treatments, with a product portfolio that includes ointments, creams, liniments, and gels. The company is recognized for its advanced manufacturing capabilities, operating multiple GMP-certified production lines that ensure high standards of quality and safety. Dongxin's market presence is bolstered by a robust distribution network and a focus on formulation innovation for topical drug delivery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Dongxin Pharmaceutical Technology.